Germany has announced a massive military expansion, signaling the potential emergence of a unified European Union army. Simultaneously, Deutsche Bank's DWS subsidiary is under investigation for "greenwashing" and exaggerating the sustainability credentials of its ESG financial products. Naomi Wolf's recent reports on Pfizer trial data are also mentioned, raising concerns about the long-term transparency of pharmaceutical research.







